Celldex Therapeutics, Inc.
Use of anti-PD-1 antibody in combination with anti-CD27 antibody in cancer treatment

Abstract:

This disclosure provides methods for treating cancer in a subject comprising administering to the subject an anti-PD-1 antibody and an anti-CD27 antibody. In some embodiments, the cancer is colorectal cancer, rectal cancer, colon cancer, lung cancer, melanoma, ovarian cancer, head and neck cancer, or any combination thereof.